Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Vitamin C with Gemcitabine and Carboplatin in Bladder Cancer
NCT04046094Phase 2Active, not recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- Oct 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in bladder cancer, sponsored by University of Kansas Medical Center. Started Oct 2019; status: active, not recruiting.
02
Drugs
ascorbic acid
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04046094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04046094.